Physician profile
Angel J Docobo
NPI 1831281864
$441.00
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $138.73 | 2019 | |
| Davol INC. | $114.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $53.32 | 2019 | |
| Tela Bio, INC. | $24.88 | 2019 | |
| Acell, INC. | $22.50 | 2019 | |
| Allergan, INC. | $20.77 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.02 | 2019 | |
| Bolder Surgical LLC | $19.34 | 2019 | |
| Smith+Nephew, INC. | $15.02 | 2019 | |
| Abbott Laboratories | $12.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Docobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.